Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
Concise Report
[키워드] Admission
Anakinra
Bacterial infection
Bacterial infections
biochemically
blockade
case sery
clinically
COVID-19
COVID-19 pandemic
Deterioration
Effect
Evidence
haemophagocytic lymphohistiocytosis
hyperinflammation
IL-1
Immunosuppression
inflammatory markers
inhibitor
intensive care
intravenous
life-threatening
objective
outcome
Oxygen requirement
Patient
patients with COVID-19
patients with moderate
patients with SARS-CoV-2
randomized trial
reduction in
Research
Result
Safe
Safety
secondary haemophagocytic lymphohistiocytosis
selective
Severe COVID-19 Infection
severe disease
subsequent
Support
the patient
utility
ventilatory support
[DOI] 10.1093/rap/rkaa040 PMC 바로가기 [Article Type] Concise Report
[DOI] 10.1093/rap/rkaa040 PMC 바로가기 [Article Type] Concise Report